158 related articles for article (PubMed ID: 36059254)
1. Factors mediating cancer risk in systemic lupus erythematosus.
Hardenbergh D; Molina E; Naik R; Geetha D; Chaturvedi S; Timlin H
Lupus; 2022 Oct; 31(11):1285-1295. PubMed ID: 36059254
[TBL] [Abstract][Full Text] [Related]
2. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
4. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
5. Malignancies in systemic lupus erythematosus: an update.
Ladouceur A; Clarke AE; Ramsey-Goldman R; Bernatsky S
Curr Opin Rheumatol; 2019 Nov; 31(6):678-681. PubMed ID: 31403485
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
7. Malignancies in systemic lupus erythematosus: a 2015 update.
Goobie GC; Bernatsky S; Ramsey-Goldman R; Clarke AE
Curr Opin Rheumatol; 2015 Sep; 27(5):454-60. PubMed ID: 26125105
[TBL] [Abstract][Full Text] [Related]
8. Managing cancer risk in patients with systemic lupus erythematous.
Ladouceur A; Bernatsky S; Ramsey-Goldman R; Clarke AE
Expert Rev Clin Immunol; 2018 Oct; 14(10):793-802. PubMed ID: 30183456
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus and malignancies.
Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
11. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
12. Malignancy in systemic lupus erythematosus: what have we learned?
Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
[TBL] [Abstract][Full Text] [Related]
13. Malignancy in Systemic Lupus Erythematosus (SLE) Patients.
Cader RA; Mei Yee AK; Yassin A; Ahmad I; Haron SN
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3551-3555. PubMed ID: 30583682
[TBL] [Abstract][Full Text] [Related]
14. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications.
Bernatsky S; Ramsey-Goldman R; Urowitz MB; Hanly JG; Gordon C; Petri MA; Ginzler EM; Wallace DJ; Bae SC; Romero-Diaz J; Dooley MA; Peschken CA; Isenberg DA; Rahman A; Manzi S; Jacobsen S; Lim SS; van Vollenhoven R; Nived O; Kamen DL; Aranow C; Ruiz-Irastorza G; Sánchez-Guerrero J; Gladman DD; Fortin PR; Alarcón GS; Merrill JT; Kalunian KC; Ramos-Casals M; Steinsson K; Zoma A; Askanase A; Khamashta MA; Bruce I; Inanc M; Clarke AE
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1789-1795. PubMed ID: 32813314
[TBL] [Abstract][Full Text] [Related]
15. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
17. Lupus and cancer.
Gayed M; Bernatsky S; Ramsey-Goldman R; Clarke A; Gordon C
Lupus; 2009 May; 18(6):479-85. PubMed ID: 19395448
[TBL] [Abstract][Full Text] [Related]
18. Exploring the links between systemic lupus erythematosus and cancer.
Bernatsky S; Ramsey-Goldman R; Clarke A
Rheum Dis Clin North Am; 2005 May; 31(2):387-402, viii-ix. PubMed ID: 15922152
[TBL] [Abstract][Full Text] [Related]
19. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
20. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
